Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

The efficacy of SMS text messages to compensate for the effects of cognitive impairments in schizophrenia.

Pijnenborg GH, Withaar FK, Brouwer WH, Timmerman ME, van den Bosch RJ, Evans JJ.

Br J Clin Psychol. 2010 Jun;49(Pt 2):259-74. doi: 10.1348/014466509X467828. Epub 2009 Sep 5.

PMID:
19735607
2.

A short message service (SMS)-based strategy for enhancing adherence to antipsychotic medication in schizophrenia.

Montes JM, Medina E, Gomez-Beneyto M, Maurino J.

Psychiatry Res. 2012 Dec 30;200(2-3):89-95. doi: 10.1016/j.psychres.2012.07.034. Epub 2012 Aug 17.

PMID:
22901437
3.

Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial.

Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S.

Schizophr Res. 2007 Aug;94(1-3):221-30. Epub 2007 May 23.

PMID:
17524620
4.

Information and communication technology based prompting for treatment compliance for people with serious mental illness.

Kauppi K, Välimäki M, Hätönen HM, Kuosmanen LM, Warwick-Smith K, Adams CE.

Cochrane Database Syst Rev. 2014 Jun 17;(6):CD009960. doi: 10.1002/14651858.CD009960.pub2. Review.

PMID:
24934254
5.

[Learning potential and cognitive remediation in schizophrenia].

Raffard S, Gely-Nargeot MC, Capdevielle D, Bayard S, Boulenger JP.

Encephale. 2009 Sep;35(4):353-60. doi: 10.1016/j.encep.2008.06.014. Epub 2009 Jan 8. Review. French.

PMID:
19748372
6.

Mobile phone messaging for facilitating self-management of long-term illnesses.

de Jongh T, Gurol-Urganci I, Vodopivec-Jamsek V, Car J, Atun R.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007459. doi: 10.1002/14651858.CD007459.pub2. Review.

PMID:
23235644
7.

Randomized controlled trial of the use of compensatory strategies to enhance adaptive functioning in outpatients with schizophrenia.

Velligan DI, Bow-Thomas CC, Huntzinger C, Ritch J, Ledbetter N, Prihoda TJ, Miller AL.

Am J Psychiatry. 2000 Aug;157(8):1317-23.

PMID:
10910797
8.

Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults.

van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H.

Cochrane Database Syst Rev. 2014 Nov 1;(11):CD011142. doi: 10.1002/14651858.CD011142.pub2. Review.

PMID:
25362239
9.

Pilot study of psychotherapeutic text messaging for depression.

Pfeiffer PN, Henry J, Ganoczy D, Piette JD.

J Telemed Telecare. 2016 Jul 21. pii: 1357633X16659955. [Epub ahead of print]

PMID:
27450571
10.

Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best?

Brüne M, Abdel-Hamid M, Lehmkämper C, Sonntag C.

Schizophr Res. 2007 May;92(1-3):151-9. Epub 2007 Mar 7.

PMID:
17346931
11.

Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.

Hogarty GE, Flesher S, Ulrich R, Carter M, Greenwald D, Pogue-Geile M, Kechavan M, Cooley S, DiBarry AL, Garrett A, Parepally H, Zoretich R.

Arch Gen Psychiatry. 2004 Sep;61(9):866-76.

PMID:
15351765
12.

Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome.

Fervaha G, Foussias G, Agid O, Remington G.

Schizophr Res. 2015 Aug;166(1-3):9-16. doi: 10.1016/j.schres.2015.04.040. Epub 2015 May 15.

PMID:
25982811
13.

Mobile phone messaging reminders for attendance at healthcare appointments.

Car J, Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R.

Cochrane Database Syst Rev. 2012 Jul 11;(7):CD007458. doi: 10.1002/14651858.CD007458.pub2. Review. Update in: Cochrane Database Syst Rev. 2013;(12):CD007458.

PMID:
22786507
14.

Mobile phone messaging reminders for attendance at healthcare appointments.

Gurol-Urganci I, de Jongh T, Vodopivec-Jamsek V, Atun R, Car J.

Cochrane Database Syst Rev. 2013 Dec 5;(12):CD007458. doi: 10.1002/14651858.CD007458.pub3. Review.

PMID:
24310741
15.

[What perspectives for cognitive remediation in schizophrenia?].

Correard N, Mazzola-Pomietto P, Elissalde SN, Viglianese-Salmon N, Fakra E, Azorin JM.

Encephale. 2011 Dec;37 Suppl 2:S155-60. doi: 10.1016/S0013-7006(11)70044-6. Review. French.

PMID:
22212847
16.
17.

Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.

Grant PM, Huh GA, Perivoliotis D, Stolar NM, Beck AT.

Arch Gen Psychiatry. 2012 Feb;69(2):121-7. doi: 10.1001/archgenpsychiatry.2011.129. Epub 2011 Oct 3.

PMID:
21969420
18.

Sustained and "sleeper" effects of group metacognitive training for schizophrenia: a randomized clinical trial.

Moritz S, Veckenstedt R, Andreou C, Bohn F, Hottenrott B, Leighton L, Köther U, Woodward TS, Treszl A, Menon M, Schneider BC, Pfueller U, Roesch-Ely D.

JAMA Psychiatry. 2014 Oct;71(10):1103-11. doi: 10.1001/jamapsychiatry.2014.1038.

PMID:
25103718
19.

An RCT of adherence therapy for people with schizophrenia in Chiang Mai, Thailand.

Maneesakorn S, Robson D, Gournay K, Gray R.

J Clin Nurs. 2007 Jul;16(7):1302-12.

PMID:
17584349
20.

Mobile phone messaging for preventive health care.

Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD007457. doi: 10.1002/14651858.CD007457.pub2. Review.

PMID:
23235643

Supplemental Content

Support Center